Royal Bank Of Canada Dr Reddys Laboratories LTD Transaction History

Royal Bank Of Canada

$528 Billion
Q2 2025

A detailed history of Royal Bank Of Canada transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Royal Bank Of Canada holds 9,962,048 shares of RDY stock, worth $139 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

9,962,048

Previous 9,050,799 10.07%

Holding current value

$139 Million

Previous $119 Million 25.42%

% of portfolio

0.03%

Previous 0.03%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$12.36 - $16.17 $11.3 Million - $14.7 Million	911,249 Added 10.07%	9,962,048 $150 Million
Q1 2025 May 15, 2025	SELL	$12.53 - $15.81 $12.4 Million - $15.6 Million	-986,447 Reduced 9.83%	9,050,799 $119 Million
Q4 2024 Feb 14, 2025	BUY	$13.99 - $79.75 $113 Million - $641 Million	8,042,163 Added 403.1%	10,037,246 $158 Million
Q3 2024 Nov 14, 2024	SELL	$75.41 - $84.21 $4.56 Million - $5.09 Million	-60,480 Reduced 2.94%	1,995,083 $159 Million
Q2 2024 Aug 14, 2024	SELL	$68.26 - $76.19 $7.43 Million - $8.29 Million	-108,782 Reduced 5.03%	2,055,563 $157 Million
Q1 2024 Nov 05, 2024	BUY	$67.36 - $77.59 $7.33 Million - $8.44 Million	108,782 Added 5.29%	2,164,345 $159 Million
Q1 2024 May 15, 2024	SELL	$67.36 - $77.59 $3.74 Million - $4.3 Million	-55,462 Reduced 2.5%	2,164,345 $159 Million
Q4 2023 Feb 14, 2024	BUY	$64.27 - $69.9 $4.66 Million - $5.07 Million	72,491 Added 3.38%	2,219,807 $154 Million
Q3 2023 Nov 14, 2023	SELL	$61.9 - $72.77 $45.7 Million - $53.8 Million	-738,856 Reduced 25.6%	2,147,316 $144 Million
Q2 2023 Aug 14, 2023	SELL	$53.34 - $63.11 $2.08 Million - $2.47 Million	-39,084 Reduced 1.34%	2,886,172 $182 Million
Q1 2023 May 15, 2023	SELL	$51.63 - $56.93 $1.16 Million - $1.28 Million	-22,514 Reduced 0.76%	2,925,256 $167 Million
Q4 2022 Feb 14, 2023	SELL	$51.15 - $57.45 $5.8 Million - $6.51 Million	-113,360 Reduced 3.7%	2,947,770 $153 Million
Q3 2022 Nov 14, 2022	SELL	$49.9 - $57.32 $8.62 Million - $9.9 Million	-172,765 Reduced 5.34%	3,061,130 $160 Million
Q2 2022 Aug 15, 2022	SELL	$49.62 - $58.13 $6.33 Million - $7.42 Million	-127,587 Reduced 3.8%	3,233,895 $179 Million
Q1 2022 May 16, 2022	SELL	$48.27 - $65.25 $2.72 Million - $3.68 Million	-56,333 Reduced 1.65%	3,361,482 $187 Million
Q4 2021 Feb 14, 2022	BUY	$59.5 - $67.25 $3.6 Million - $4.07 Million	60,448 Added 1.8%	3,417,815 $224 Million
Q3 2021 Nov 15, 2021	BUY	$60.19 - $75.29 $1.44 Million - $1.8 Million	23,859 Added 0.72%	3,357,367 $219 Million
Q2 2021 Aug 16, 2021	BUY	$62.12 - $74.2 $207 Million - $247 Million	3,333,508 New	3,333,508 $245 Million

Others Institutions Holding RDY

# of Institutions

262

Shares Held

92.5M

Call Options Held

Put Options Held

View Full List

About DR REDDYS LABORATORIES LTD

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $2.31B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

More about RDY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Dr Reddys Laboratories LTD Transaction History